Management of Iron Deficiency in Heart Failure: Practical Considerations and Implementation of Evidence-Based Iron...

Area of Science:

• Cardiology
• Hematology
• Internal Medicine

Background:

• Iron deficiency (ID) is highly prevalent in heart failure (HF) patients, reaching up to 80% in the post-acute setting.
• Current guidelines recommend intravenous (IV) iron for HF patients with ID and reduced ejection fraction, citing improved quality of life, exercise capacity, and reduced hospitalizations.

Purpose of the Study:

• To discuss practical considerations for treating ID in HF patients.
• To explore strategies for implementing evidence-based IV iron therapy, addressing health disparities.
• To review inclusion/exclusion criteria, clinical controversies, and evidence gaps in ID treatment for HF.

Main Methods:

• This is a review article.
• It synthesizes current evidence and guidelines regarding IV iron supplementation in HF.
• It identifies barriers to implementation and proposes solutions.

Main Results:

• Significant barriers exist in routine IV iron implementation, including clinician knowledge gaps and resource limitations.
• Effective implementation requires addressing these barriers with toolkits and standardized protocols.
• Evidence gaps and clinical controversies require further investigation.

Conclusions:

• Optimizing IV iron therapy for HF patients with ID is crucial for improving patient outcomes.
• Addressing practical barriers and standardizing treatment protocols are essential for widespread, equitable implementation.
• Further research is needed to address existing evidence gaps and clinical controversies.